Processa Pharmaceuticals logo
Processa Pharmaceuticals PCSA
$ 1.37 5.38%

Quarterly report 2024-Q2
added 08-13-2024

report update icon

Processa Pharmaceuticals Long Term Debt 2011-2024 | PCSA

Annual Long Term Debt Processa Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
66.9 K 151 K 7.38 K 44.9 K - - - - - 494 K 145 K 606 K 2.2 M

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
2.2 M 7.38 K 464 K

Quarterly Long Term Debt Processa Pharmaceuticals

2024-Q2 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
3.82 K - 88.8 K 109 K 129 K 151 K 172 K 4.66 K 6.15 K 7.38 K 8.77 K 30.9 K 47.4 K 78.5 K 78.5 K 78.5 K 78.5 K 147 K 147 K 147 K 147 K - - - - - - - - - - - - - 27.5 K - - 360 K 360 K 360 K 360 K - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
360 K 3.82 K 125 K